Patent 11878145 was granted and assigned to Ypsomed on January, 2024 by the United States Patent and Trademark Office.
The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient using a closed loop artificial pancreas. The systems and methods may utilize a controller with control logic operative to execute a multi-model predictive controller algorithm to determine a medication dose to the patient.